Prevalence of wild-type in NS5A-PKR protein kinase binding domain in HCV-related hepatocellular carcinoma

Maria Stella De Mitri, Giulia Morsica, Romina Cassini, Sabrina Bagaglio, Marco Zoli, Alfredo Alberti, Mauro Bernardi

Research output: Contribution to journalArticle

Abstract

Background/Aims: Experimental studies have demonstrated that the wild-type PKR-NS5A strain of hepatitis C virus (HCV) may have oncogenic potential through the binding and functional repression of PKR protein kinase. To assess whether the NS5A-PKR-binding domain may be involved in HCV-related liver carcinogenesis, its sequence was analyzed in the sera of 85 patients with hepatocellular carcinoma (HCC) and in 51 patients with chronic active hepatitis (CAH). In 13 HCC cases sequence analysis was also performed in tumor and nontumor liver tissues. Methods: The nucleotide sequences of the PKR-binding domain were inferred by direct sequencing of the amplified HCV products and deduced amino acids were cpmpared with the sequence of HCV-J. Results: A wild-type or single mutated strain which retains PKR-binding activity was found in 88% of HCC and 69% of CAH cases (P = 0.0096). All but three HCC cases showed no divergences in amino acid changes between serum and liver tissues. The wild-type strains were equally distributed between the HCC with or without cirrhosis. Conclusions: The prevalence of the wild-type NS5A-PKR strain is significantly higher in HCC than in CAH. These data suggest that inhibition of PKR activity by HCV might represent a potential mechanism of HCV-related carcinogenesis.

Original languageEnglish
Pages (from-to)116-122
Number of pages7
JournalJournal of Hepatology
Volume36
Issue number1
DOIs
Publication statusPublished - 2002

Keywords

  • Chronic hepatitis
  • Hepatitis C virus
  • Hepatocellular carcinoma
  • Nonstructural 5A
  • PKR protein kinase

ASJC Scopus subject areas

  • Gastroenterology

Fingerprint Dive into the research topics of 'Prevalence of wild-type in NS5A-PKR protein kinase binding domain in HCV-related hepatocellular carcinoma'. Together they form a unique fingerprint.

Cite this